DSGN
Price
$9.39
Change
-$0.40 (-4.08%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
558.24M
61 days until earnings call
Intraday BUY SELL Signals
RGNX
Price
$13.76
Change
-$1.19 (-7.96%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
756.82M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DSGN vs RGNX

Header iconDSGN vs RGNX Comparison
Open Charts DSGN vs RGNXBanner chart's image
Design Therapeutics
Price$9.39
Change-$0.40 (-4.08%)
Volume$1.81K
Capitalization558.24M
REGENXBIO
Price$13.76
Change-$1.19 (-7.96%)
Volume$9.68K
Capitalization756.82M
DSGN vs RGNX Comparison Chart in %
DSGN
Daily Signal:
Gain/Loss:
RGNX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DSGN vs. RGNX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (DSGN: $9.80 vs. RGNX: $14.95)
Brand notoriety: DSGN and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 27% vs. RGNX: 79%
Market capitalization -- DSGN: $558.24M vs. RGNX: $756.82M
DSGN [@Biotechnology] is valued at $558.24M. RGNX’s [@Biotechnology] market capitalization is $756.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 2 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • DSGN’s TA Score: 2 bullish, 5 bearish.
  • RGNX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than DSGN.

Price Growth

DSGN (@Biotechnology) experienced а -0.71% price change this week, while RGNX (@Biotechnology) price change was -1.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

DSGN is expected to report earnings on Mar 17, 2026.

RGNX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($757M) has a higher market cap than DSGN($558M). DSGN YTD gains are higher at: 4.478 vs. RGNX (3.819). DSGN has higher annual earnings (EBITDA): -77.38M vs. RGNX (-120M). RGNX has more cash in the bank: 274M vs. DSGN (206M). DSGN has less debt than RGNX: DSGN (1.74M) vs RGNX (76.5M). RGNX has higher revenues than DSGN: RGNX (161M) vs DSGN (0).
DSGNRGNXDSGN / RGNX
Capitalization558M757M74%
EBITDA-77.38M-120M64%
Gain YTD4.4783.819117%
P/E RatioN/AN/A-
Revenue0161M-
Total Cash206M274M75%
Total Debt1.74M76.5M2%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNRGNX
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signal:
Gain/Loss:
RGNX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMDAX20.680.09
+0.44%
Principal Small-MidCap Dividend Inc A
OAYBX39.680.13
+0.33%
Oakmark Equity and Income Advisor
WHGIX13.200.03
+0.23%
Westwood Income Opportunity Instl
FHEAX15.01N/A
N/A
Fidelity Advisor Real Estate A
SUTCX3.88-0.01
-0.26%
AB Sustainable US Thematic C

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
+2.40%
IDYA - DSGN
51%
Loosely correlated
+5.53%
DYN - DSGN
50%
Loosely correlated
+2.41%
SLDB - DSGN
49%
Loosely correlated
+12.60%
AURA - DSGN
48%
Loosely correlated
+3.95%
RGNX - DSGN
48%
Loosely correlated
-0.66%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with SYRE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-0.66%
SYRE - RGNX
56%
Loosely correlated
+5.17%
BEAM - RGNX
55%
Loosely correlated
+2.49%
VYGR - RGNX
55%
Loosely correlated
+2.74%
XNCR - RGNX
54%
Loosely correlated
+3.66%
DNLI - RGNX
52%
Loosely correlated
+0.88%
More